European pharma is spared worst-case U.S. tariffs. Investors still don't trust the deal
- Posted on August 21, 2025
- By CNBC
- 1 Views
European pharma is spared worst-case U.S. tariffs. Investors still don't trust the deal
Markets failed to rally despite what analysts said was a clear win for the European pharmaceutical sector in a trade update Thursday.
